<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00928408</url>
  </required_header>
  <id_info>
    <org_study_id>20070363</org_study_id>
    <secondary_id>PRIMARA</secondary_id>
    <nct_id>NCT00928408</nct_id>
  </id_info>
  <brief_title>PRIMARA: A Prospective Descriptive Observational Study to Review Mimpara (Cinacalcet) Use in Patients With Primary Hyperparathyroidism in Clinical Practice</brief_title>
  <official_title>PRIMARA: A Prospective Descriptive Observational Study to Review Mimpara (Cinacalcet) Use in Patients With Primary Hyperparathyroidism in Clinical Practice</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Amgen</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Amgen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multicentre, descriptive observational study of adult patients with primary HPT
      receiving cinacalcet in clinical practice in a number of countries in Europe. Patients will
      be enrolled within 1 month of initiating cinacalcet treatment, and data will be collected
      prospectively for up to 1 year from initiation. Data will continue to be collected from
      patients discontinuing cinacalcet before the end of this period.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">February 2012</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cinacalcet Dose</measure>
    <time_frame>Initiation of treatment</time_frame>
    <description>Cinacalcet dose at initiation of treatment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cinacalcet Dose</measure>
    <time_frame>Month 3</time_frame>
    <description>Cinacalcet dose at Month 3</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cinacalcet Dose</measure>
    <time_frame>Month 6</time_frame>
    <description>Cinacalcet dose at Month 6</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cinacalcet Dose</measure>
    <time_frame>Month 12</time_frame>
    <description>Cinacalcet dose at Month 12</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cinacalcet Dose</measure>
    <time_frame>Up to Month 12</time_frame>
    <description>Cinacalcet dose at end of treatment (last dose received)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cinacalcet Dosing Frequency</measure>
    <time_frame>Initiation of treatment</time_frame>
    <description>Cinacalcet dosing frequency at initiation of treatment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cinacalcet Dosing Frequency</measure>
    <time_frame>Month 3</time_frame>
    <description>Cinacalcet dosing frequency at Month 3</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cinacalcet Dosing Frequency</measure>
    <time_frame>Month 6</time_frame>
    <description>Cinacalcet dosing frequency at Month 6</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cinacalcet Dosing Frequency</measure>
    <time_frame>Month 12</time_frame>
    <description>Cinacalcet dosing frequency at Month 12</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cinacalcet Dosing Frequency</measure>
    <time_frame>Up to Month 12</time_frame>
    <description>Cinacalcet dosing frequency at end of treatment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Occurrence of a Change in Cinacalcet Dose or Frequency During the First 3 Months After Initiation</measure>
    <time_frame>Initiation to Month 3</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Occurrence of a Change in Cinacalcet Dose or Frequency &gt;3 to 6 Months After Initiation</measure>
    <time_frame>&gt;3 to 6 months after initiation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Occurrence of a Change in Cinacalcet Dose or Frequency &gt;6 Months After Initiation</measure>
    <time_frame>&gt;6 months after initiation</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of Exposure to Cinacalcet</measure>
    <time_frame>12 months</time_frame>
    <description>Time from first dose to last non-zero dose on study</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Achievement of a Reduction From Baseline of Albumin-corrected Serum Calcium ≥ 0.25 mmol/L (1 mg/dL) at Month 3</measure>
    <time_frame>Month 3</time_frame>
    <description>Baseline is pre-cinacalcet.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Achievement of a Reduction From Baseline of Albumin-corrected Serum Calcium ≥ 0.25 mmol/L (1 mg/dL) at Month 6</measure>
    <time_frame>Month 6</time_frame>
    <description>Baseline is pre-cinacalcet.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Achievement of a Reduction From Baseline of Albumin-corrected Serum Calcium ≥ 0.25 mmol/L (1 mg/dL) at Month 12</measure>
    <time_frame>Month 12</time_frame>
    <description>Baseline is pre-cinacalcet.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of an Albumin-corrected Serum Calcium Concentration ≤ 2.6 mmol/L (10.3 mg/dL) at Month 3</measure>
    <time_frame>Month 3</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of an Albumin-corrected Serum Calcium Concentration ≤ 2.6 mmol/L (10.3 mg/dL) at Month 6</measure>
    <time_frame>Month 6</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of an Albumin-corrected Serum Calcium Concentration ≤ 2.6 mmol/L (10.3 mg/dL) at Month 12</measure>
    <time_frame>Month 12</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline to Month 3 in Albumin-corrected Serum Calcium</measure>
    <time_frame>Baseline to Month 3</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline to Month 6 in Albumin-corrected Serum Calcium</measure>
    <time_frame>Baseline to Month 6</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline to Month 12 in Albumin-corrected Serum Calcium</measure>
    <time_frame>Baseline to Month 12</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percent Change From Baseline to Month 12 in Bone Mineral Density (g/cm^2). Anatomic Site: Femoral Neck; Densitometer: Hologic</measure>
    <time_frame>Baseline to Month 12</time_frame>
    <description>Results only shown where &gt;10 patients have data</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percent Change From Baseline to Month 12 in Bone Mineral Density (g/cm^2). Anatomic Site: Lumbar Spine; Densitometer: Hologic</measure>
    <time_frame>Baseline to Month 12</time_frame>
    <description>Results only shown where &gt;10 patients have data</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reason for Prescribing Cinacalcet</measure>
    <time_frame>Initiation</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">305</enrollment>
  <condition>Hyperparathyroidism, Primary</condition>
  <arm_group>
    <arm_group_label>Cinacalcet</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cinacalcet</intervention_name>
    <arm_group_label>Cinacalcet</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients with primary HPT receiving cinacalcet in clinical practice
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  at least 18 years of age at the time of first administration of cinacalcet

          -  patients with primary HPT who have initiated cinacalcet within 1 month before
             enrolment in the study

          -  provision of informed consent (if required)

        Exclusion Criteria:

          -  previous use of cinacalcet (other than within 1 month before enrolment)

          -  diagnosed secondary HPT

          -  other known aetiology of hypercalcaemia (eg, sarcoidosis, tuberculosis)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>MD</last_name>
    <role>Study Director</role>
    <affiliation>Amgen</affiliation>
  </overall_official>
  <removed_countries>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Czech Republic</country>
    <country>Denmark</country>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Slovakia</country>
    <country>Spain</country>
    <country>United Kingdom</country>
  </removed_countries>
  <link>
    <url>http://www.amgentrials.com</url>
    <description>AmgenTrials clinical trials website</description>
  </link>
  <reference>
    <citation>Langdahl BL, Ralston SH. Diagnosis and management of primary hyperparathyroidism in Europe. QJM. 2012 Jun;105(6):519-25. doi: 10.1093/qjmed/hcr225. Epub 2012 May 7.</citation>
    <PMID>22566664</PMID>
  </reference>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 25, 2009</study_first_submitted>
  <study_first_submitted_qc>June 25, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 26, 2009</study_first_posted>
  <results_first_submitted>February 5, 2013</results_first_submitted>
  <results_first_submitted_qc>September 10, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 14, 2013</results_first_posted>
  <last_update_submitted>July 18, 2014</last_update_submitted>
  <last_update_submitted_qc>July 18, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 25, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperparathyroidism</mesh_term>
    <mesh_term>Hyperparathyroidism, Primary</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cinacalcet Hydrochloride</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Cinacalcet</title>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="305">Number Enrolled</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>Full Analysis Set</title>
              <participants_list>
                <participants group_id="P1" count="303">All enrolled participants who fulfilled the study inclusion/exclusion criteria</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="282"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Cinacalcet</title>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="303"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67.4" spread="13.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="241"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="104"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White or Caucasion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="199"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Cinacalcet Dose</title>
        <description>Cinacalcet dose at initiation of treatment</description>
        <time_frame>Initiation of treatment</time_frame>
        <population>Full Analysis Set</population>
        <group_list>
          <group group_id="O1">
            <title>Cinacalcet</title>
          </group>
        </group_list>
        <measure>
          <title>Cinacalcet Dose</title>
          <description>Cinacalcet dose at initiation of treatment</description>
          <population>Full Analysis Set</population>
          <units>mg/day</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="303"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.9" spread="0.9" lower_limit="42.1" upper_limit="45.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Cinacalcet Dose</title>
        <description>Cinacalcet dose at Month 3</description>
        <time_frame>Month 3</time_frame>
        <population>Full Analysis Set - Participants with Observed Data</population>
        <group_list>
          <group group_id="O1">
            <title>Cinacalcet</title>
          </group>
        </group_list>
        <measure>
          <title>Cinacalcet Dose</title>
          <description>Cinacalcet dose at Month 3</description>
          <population>Full Analysis Set - Participants with Observed Data</population>
          <units>mg/day</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="255"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.7" spread="0.9" lower_limit="44.9" upper_limit="52.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Cinacalcet Dose</title>
        <description>Cinacalcet dose at Month 6</description>
        <time_frame>Month 6</time_frame>
        <population>Full Analysis Set - Participants with Observed Data</population>
        <group_list>
          <group group_id="O1">
            <title>Cinacalcet</title>
          </group>
        </group_list>
        <measure>
          <title>Cinacalcet Dose</title>
          <description>Cinacalcet dose at Month 6</description>
          <population>Full Analysis Set - Participants with Observed Data</population>
          <units>mg/day</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="233"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.9" spread="0.9" lower_limit="44.9" upper_limit="52.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Cinacalcet Dose</title>
        <description>Cinacalcet dose at Month 12</description>
        <time_frame>Month 12</time_frame>
        <population>Full Analysis Set - Participants with Observed Data</population>
        <group_list>
          <group group_id="O1">
            <title>Cinacalcet</title>
          </group>
        </group_list>
        <measure>
          <title>Cinacalcet Dose</title>
          <description>Cinacalcet dose at Month 12</description>
          <population>Full Analysis Set - Participants with Observed Data</population>
          <units>mg/day</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="219"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.3" spread="0.9" lower_limit="47.0" upper_limit="55.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Cinacalcet Dose</title>
        <description>Cinacalcet dose at end of treatment (last dose received)</description>
        <time_frame>Up to Month 12</time_frame>
        <population>Full Analysis Set</population>
        <group_list>
          <group group_id="O1">
            <title>Cinacalcet</title>
          </group>
        </group_list>
        <measure>
          <title>Cinacalcet Dose</title>
          <description>Cinacalcet dose at end of treatment (last dose received)</description>
          <population>Full Analysis Set</population>
          <units>mg/day</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="303"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.1" spread="0.9" lower_limit="49.2" upper_limit="57.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Cinacalcet Dosing Frequency</title>
        <description>Cinacalcet dosing frequency at initiation of treatment</description>
        <time_frame>Initiation of treatment</time_frame>
        <population>Full Analysis Set</population>
        <group_list>
          <group group_id="O1">
            <title>Cinacalcet</title>
          </group>
        </group_list>
        <measure>
          <title>Cinacalcet Dosing Frequency</title>
          <description>Cinacalcet dosing frequency at initiation of treatment</description>
          <population>Full Analysis Set</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="303"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Once a day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="169" spread="0.9" lower_limit="49.2" upper_limit="57.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Twice a day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="134"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Cinacalcet Dosing Frequency</title>
        <description>Cinacalcet dosing frequency at Month 3</description>
        <time_frame>Month 3</time_frame>
        <population>Full Analysis Set - Participants with Observed Data</population>
        <group_list>
          <group group_id="O1">
            <title>Cinacalcet</title>
          </group>
        </group_list>
        <measure>
          <title>Cinacalcet Dosing Frequency</title>
          <description>Cinacalcet dosing frequency at Month 3</description>
          <population>Full Analysis Set - Participants with Observed Data</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="255"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Once a day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="133" spread="0.9" lower_limit="49.2" upper_limit="57.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Twice a day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="107"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Three times a day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Four times a day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dose withheld</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Cinacalcet Dosing Frequency</title>
        <description>Cinacalcet dosing frequency at Month 6</description>
        <time_frame>Month 6</time_frame>
        <population>Full Analysis Set - Participants with Observed Data</population>
        <group_list>
          <group group_id="O1">
            <title>Cinacalcet</title>
          </group>
        </group_list>
        <measure>
          <title>Cinacalcet Dosing Frequency</title>
          <description>Cinacalcet dosing frequency at Month 6</description>
          <population>Full Analysis Set - Participants with Observed Data</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="233"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Once a day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="128" spread="0.9" lower_limit="49.2" upper_limit="57.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Twice a day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Three times a day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dose withheld</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Cinacalcet Dosing Frequency</title>
        <description>Cinacalcet dosing frequency at Month 12</description>
        <time_frame>Month 12</time_frame>
        <population>Full Analysis Set - Participants with Observed Data</population>
        <group_list>
          <group group_id="O1">
            <title>Cinacalcet</title>
          </group>
        </group_list>
        <measure>
          <title>Cinacalcet Dosing Frequency</title>
          <description>Cinacalcet dosing frequency at Month 12</description>
          <population>Full Analysis Set - Participants with Observed Data</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="219"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Once a day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="121" spread="0.9" lower_limit="49.2" upper_limit="57.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Twice a day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Three times a day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Cinacalcet Dosing Frequency</title>
        <description>Cinacalcet dosing frequency at end of treatment</description>
        <time_frame>Up to Month 12</time_frame>
        <population>Full Analysis Set</population>
        <group_list>
          <group group_id="O1">
            <title>Cinacalcet</title>
          </group>
        </group_list>
        <measure>
          <title>Cinacalcet Dosing Frequency</title>
          <description>Cinacalcet dosing frequency at end of treatment</description>
          <population>Full Analysis Set</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="303"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Once a day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="168" spread="0.9" lower_limit="49.2" upper_limit="57.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Twice a day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="118"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Three times a day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Four times a day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Occurrence of a Change in Cinacalcet Dose or Frequency During the First 3 Months After Initiation</title>
        <time_frame>Initiation to Month 3</time_frame>
        <population>Full Analysis Set</population>
        <group_list>
          <group group_id="O1">
            <title>Cinacalcet</title>
          </group>
        </group_list>
        <measure>
          <title>Occurrence of a Change in Cinacalcet Dose or Frequency During the First 3 Months After Initiation</title>
          <population>Full Analysis Set</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="303"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" spread="0.9" lower_limit="49.2" upper_limit="57.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="203"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Occurrence of a Change in Cinacalcet Dose or Frequency &gt;3 to 6 Months After Initiation</title>
        <time_frame>&gt;3 to 6 months after initiation</time_frame>
        <population>Full Analysis Set - Participants with Observed Data</population>
        <group_list>
          <group group_id="O1">
            <title>Cinacalcet</title>
          </group>
        </group_list>
        <measure>
          <title>Occurrence of a Change in Cinacalcet Dose or Frequency &gt;3 to 6 Months After Initiation</title>
          <population>Full Analysis Set - Participants with Observed Data</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="255"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45" spread="0.9" lower_limit="49.2" upper_limit="57.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="210"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Occurrence of a Change in Cinacalcet Dose or Frequency &gt;6 Months After Initiation</title>
        <time_frame>&gt;6 months after initiation</time_frame>
        <population>Full Analysis Set - Participants with Observed Data</population>
        <group_list>
          <group group_id="O1">
            <title>Cinacalcet</title>
          </group>
        </group_list>
        <measure>
          <title>Occurrence of a Change in Cinacalcet Dose or Frequency &gt;6 Months After Initiation</title>
          <population>Full Analysis Set - Participants with Observed Data</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="233"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51" spread="0.9" lower_limit="49.2" upper_limit="57.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="182"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Duration of Exposure to Cinacalcet</title>
        <description>Time from first dose to last non-zero dose on study</description>
        <time_frame>12 months</time_frame>
        <population>Full Analysis Set</population>
        <group_list>
          <group group_id="O1">
            <title>Cinacalcet</title>
          </group>
        </group_list>
        <measure>
          <title>Duration of Exposure to Cinacalcet</title>
          <description>Time from first dose to last non-zero dose on study</description>
          <population>Full Analysis Set</population>
          <units>Days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="303"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="366" spread="7.3" lower_limit="232" upper_limit="366"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Achievement of a Reduction From Baseline of Albumin-corrected Serum Calcium ≥ 0.25 mmol/L (1 mg/dL) at Month 3</title>
        <description>Baseline is pre-cinacalcet.</description>
        <time_frame>Month 3</time_frame>
        <population>Full Analysis Set - Participants with Observed Data</population>
        <group_list>
          <group group_id="O1">
            <title>Cinacalcet</title>
          </group>
        </group_list>
        <measure>
          <title>Achievement of a Reduction From Baseline of Albumin-corrected Serum Calcium ≥ 0.25 mmol/L (1 mg/dL) at Month 3</title>
          <description>Baseline is pre-cinacalcet.</description>
          <population>Full Analysis Set - Participants with Observed Data</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="180"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="101" spread="0.9" lower_limit="49.2" upper_limit="57.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Achievement of a Reduction From Baseline of Albumin-corrected Serum Calcium ≥ 0.25 mmol/L (1 mg/dL) at Month 6</title>
        <description>Baseline is pre-cinacalcet.</description>
        <time_frame>Month 6</time_frame>
        <population>Full Analysis Set - Participants with Observed Data</population>
        <group_list>
          <group group_id="O1">
            <title>Cinacalcet</title>
          </group>
        </group_list>
        <measure>
          <title>Achievement of a Reduction From Baseline of Albumin-corrected Serum Calcium ≥ 0.25 mmol/L (1 mg/dL) at Month 6</title>
          <description>Baseline is pre-cinacalcet.</description>
          <population>Full Analysis Set - Participants with Observed Data</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="152"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95" spread="0.9" lower_limit="49.2" upper_limit="57.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Achievement of a Reduction From Baseline of Albumin-corrected Serum Calcium ≥ 0.25 mmol/L (1 mg/dL) at Month 12</title>
        <description>Baseline is pre-cinacalcet.</description>
        <time_frame>Month 12</time_frame>
        <population>Full Analysis Set - Participants with Observed Data</population>
        <group_list>
          <group group_id="O1">
            <title>Cinacalcet</title>
          </group>
        </group_list>
        <measure>
          <title>Achievement of a Reduction From Baseline of Albumin-corrected Serum Calcium ≥ 0.25 mmol/L (1 mg/dL) at Month 12</title>
          <description>Baseline is pre-cinacalcet.</description>
          <population>Full Analysis Set - Participants with Observed Data</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="117"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70" spread="0.9" lower_limit="49.2" upper_limit="57.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Incidence of an Albumin-corrected Serum Calcium Concentration ≤ 2.6 mmol/L (10.3 mg/dL) at Month 3</title>
        <time_frame>Month 3</time_frame>
        <population>Full Analysis Set - Participants with Observed Data</population>
        <group_list>
          <group group_id="O1">
            <title>Cinacalcet</title>
          </group>
        </group_list>
        <measure>
          <title>Incidence of an Albumin-corrected Serum Calcium Concentration ≤ 2.6 mmol/L (10.3 mg/dL) at Month 3</title>
          <population>Full Analysis Set - Participants with Observed Data</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="220"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="138" spread="0.9" lower_limit="49.2" upper_limit="57.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Incidence of an Albumin-corrected Serum Calcium Concentration ≤ 2.6 mmol/L (10.3 mg/dL) at Month 6</title>
        <time_frame>Month 6</time_frame>
        <population>Full Analysis Set - Participants with Observed Data</population>
        <group_list>
          <group group_id="O1">
            <title>Cinacalcet</title>
          </group>
        </group_list>
        <measure>
          <title>Incidence of an Albumin-corrected Serum Calcium Concentration ≤ 2.6 mmol/L (10.3 mg/dL) at Month 6</title>
          <population>Full Analysis Set - Participants with Observed Data</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="193"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="134" spread="0.9" lower_limit="49.2" upper_limit="57.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Incidence of an Albumin-corrected Serum Calcium Concentration ≤ 2.6 mmol/L (10.3 mg/dL) at Month 12</title>
        <time_frame>Month 12</time_frame>
        <population>Full Analysis Set - Participants with Observed Data</population>
        <group_list>
          <group group_id="O1">
            <title>Cinacalcet</title>
          </group>
        </group_list>
        <measure>
          <title>Incidence of an Albumin-corrected Serum Calcium Concentration ≤ 2.6 mmol/L (10.3 mg/dL) at Month 12</title>
          <population>Full Analysis Set - Participants with Observed Data</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="148"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="105" spread="0.9" lower_limit="49.2" upper_limit="57.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline to Month 3 in Albumin-corrected Serum Calcium</title>
        <time_frame>Baseline to Month 3</time_frame>
        <population>Full Analysis Set - Participants with Observed Data</population>
        <group_list>
          <group group_id="O1">
            <title>Cinacalcet</title>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline to Month 3 in Albumin-corrected Serum Calcium</title>
          <population>Full Analysis Set - Participants with Observed Data</population>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="161"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.32" spread="0.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline to Month 6 in Albumin-corrected Serum Calcium</title>
        <time_frame>Baseline to Month 6</time_frame>
        <population>Full Analysis Set - Participants with Observed Data</population>
        <group_list>
          <group group_id="O1">
            <title>Cinacalcet</title>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline to Month 6 in Albumin-corrected Serum Calcium</title>
          <population>Full Analysis Set - Participants with Observed Data</population>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="127"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.35" spread="0.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline to Month 12 in Albumin-corrected Serum Calcium</title>
        <time_frame>Baseline to Month 12</time_frame>
        <population>Full Analysis Set - Participants with Observed Data</population>
        <group_list>
          <group group_id="O1">
            <title>Cinacalcet</title>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline to Month 12 in Albumin-corrected Serum Calcium</title>
          <population>Full Analysis Set - Participants with Observed Data</population>
          <units>mmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="109"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.36" spread="0.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percent Change From Baseline to Month 12 in Bone Mineral Density (g/cm^2). Anatomic Site: Femoral Neck; Densitometer: Hologic</title>
        <description>Results only shown where &gt;10 patients have data</description>
        <time_frame>Baseline to Month 12</time_frame>
        <population>Full Analysis Set - Participants with Observed Data</population>
        <group_list>
          <group group_id="O1">
            <title>Cinacalcet</title>
          </group>
        </group_list>
        <measure>
          <title>Percent Change From Baseline to Month 12 in Bone Mineral Density (g/cm^2). Anatomic Site: Femoral Neck; Densitometer: Hologic</title>
          <description>Results only shown where &gt;10 patients have data</description>
          <population>Full Analysis Set - Participants with Observed Data</population>
          <units>Percent change</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.82" spread="5.26" lower_limit="-1.63" upper_limit="2.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percent Change From Baseline to Month 12 in Bone Mineral Density (g/cm^2). Anatomic Site: Lumbar Spine; Densitometer: Hologic</title>
        <description>Results only shown where &gt;10 patients have data</description>
        <time_frame>Baseline to Month 12</time_frame>
        <population>Full Analysis Set - Participants with Observed Data</population>
        <group_list>
          <group group_id="O1">
            <title>Cinacalcet</title>
          </group>
        </group_list>
        <measure>
          <title>Percent Change From Baseline to Month 12 in Bone Mineral Density (g/cm^2). Anatomic Site: Lumbar Spine; Densitometer: Hologic</title>
          <description>Results only shown where &gt;10 patients have data</description>
          <population>Full Analysis Set - Participants with Observed Data</population>
          <units>Percent change</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.16" spread="9.56" lower_limit="-3.89" upper_limit="2.70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Reason for Prescribing Cinacalcet</title>
        <time_frame>Initiation</time_frame>
        <population>Full Analysis Set</population>
        <group_list>
          <group group_id="O1">
            <title>Cinacalcet</title>
          </group>
        </group_list>
        <measure>
          <title>Reason for Prescribing Cinacalcet</title>
          <population>Full Analysis Set</population>
          <units>Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="303"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Failed surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33" spread="0.9" lower_limit="49.2" upper_limit="57.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Surgery contraindicated</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Surgery not considered appropriate by physician</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="107"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Reduction of hypercalcaemia before surgery</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Surgery declined by patient</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>12 months</time_frame>
      <desc>The table of Other Adverse Events summarizes the most frequent non-serious occurrences of adverse events.
Only adverse drug reactions to cinacalcet were collected. Analysis is based on the Full Analysis Set (all enrolled who fulfilled study inclusion/exclusion criteria).</desc>
      <group_list>
        <group group_id="E1">
          <title>Cinacalcet</title>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 14.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="303"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Hypocalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="303"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="303"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Circulatory collapse</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="303"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 14.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="41" subjects_at_risk="303"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="41" subjects_at_risk="303"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The Clinical Trial Agreement generally does not restrict an investigator’s discussion of trial results after completion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multi-center studies, the investigator agrees not to publish any results before the first multi-center publication.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Study Director</name_or_title>
      <organization>Amgen Inc.</organization>
      <phone>866-572-6436</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

